Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
New crypto investors should know key insights to thrive in the market. Equip yourself with the right information for success.
28,386 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Palantir reports strong government revenue growth while warning that adversaries are increasingly targeting AI data c...
Scott Bessent used a CNBC interview to frame Mamdani as a central Democratic figure and to outline a bold plan to bro...
A new realtor.com analysis questions whether a Senate plan to curb large investors in single-family homes will meanin...
Dell fell about 6% as memory costs squeezed margins, while Western Digital rose around 5% on continued AI-driven dema...
Two discount retailers face off for 2026 returns, with Dollar Tree highlighting a store-format push and Dollar Genera...
Wendy's has surged about 40% over the past week, attracting intense options activity and renewed bets on a turnaround...
A growth stock that surged to lofty heights last year has cooled in 2026, but big buyers keep stepping in as AI capac...
June delivered a sharp pause as the Magnificent Seven shed trillions, signaling a shift toward chipmakers and AI infr...
Disney faces a growing disney narrative problem wall as Wall Street questions leadership, strategy, and long-term pro...
Retail traders surged through May and June 2026, lifting volumes and reshaping daily moves. Five charts reveal how ch...
Chevron reports stronger-than-expected Q1 2026 results and advancing Hess synergy-driven production, but investors de...